Researchers have found that children of women with HIV infection have an increased risk of immune abnormalities following exposure to maternal HIV viremia, immune dysfunction, and co-infections d...
https://medicalxpress.com/news/2024-04-uncovers-boys-born-mothers-hiv.html
New data from an implementation program to be presented at this year's the ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27–30 April) stress that the global HIV epidemic cannot ...
https://medicalxpress.com/news/2024-04-hiv-epidemic-prisoners-patients-lost.html
A chemical modification in the HIV-1 RNA genome whose function has been a matter of scientific debate is now confirmed to be key to the virus's ability to survive and thrive after infecting host ...
https://medicalxpress.com/news/2024-04-rna-chemical-modifications-benefit-hiv.html
The U.S. Food and Drug Administration has approved Dovato (dolutegravir/lamivudine) for adolescents living with HIV.
https://medicalxpress.com/news/2024-04-fda-dovato-teens-hiv.html
The Wistar Institute's associate professor Mohamed Abdel-Mohsen, Ph.D., along with his team and collaborators, has identified sugar abnormalities in the blood that may promote biological aging an...
https://medicalxpress.com/news/2024-04-scientists-pro-aging-sugar-signature.html
NeuroHIV refers to the effects of HIV infection on the brain or central nervous system, and to some extent, the spinal cord and peripheral nervous system. A collection of diseases, including neur...
https://medicalxpress.com/news/2024-04-small-protein-plays-big-role.html
A new study has found that increased coronary vessel wall thickness is significantly associated with impaired diastolic function in asymptomatic, middle-aged individuals living with HIV. The stud...
https://medicalxpress.com/news/2024-04-early-coronary-disease-impaired-heart.html
In a Pittsburgh hospital in the early 1980s, Charles Rinaldo saw a young, previously healthy gay man critically ill with a virus usually only seen in weakened immune systems.
https://medicalxpress.com/news/2024-04-greatest-pitt-men-years-aids.html
Through his office window at what was then one of Africa's few modern clinics dealing with HIV and AIDS, the man who now oversees the United States' threatened global AIDS effort used to hear the...
https://medicalxpress.com/news/2024-04-america-embattled-global-hiv-recalls.html
In their research article published in Eurosurveillance, von Schreeb et al. challenge existing assumptions regarding the relationship between the use of HIV pre-exposure prophylaxis (PrEP) and th...
https://medicalxpress.com/news/2024-03-exploring-relationship-hiv-pre-exposure.html
A new research review to be presented at a pre-congress day for this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2024) will focus on the growing prevalence of ...
https://medicalxpress.com/news/2024-03-hiv-countries-age-higher-frailty.html
A team from Houston Methodist Research Institute recently showed that a nanofluidic implant delivered an HIV drug that achieved more potency than other forms of drug administration (oral) and oth...
https://medicalxpress.com/news/2024-03-implantable-device-hiv-antiviral-potency.html
By 2030, the World Health Organization (WHO), the Global Fund and UNAIDS are hoping to end the human immunodeficiency virus (HIV) and AIDS epidemic. An international team of researchers led by Er...
https://medicalxpress.com/news/2024-03-virus-particle-effectively-latent-hiv.html
A study by Allison Appleton, Mark Kuniholm and Elizabeth Vásquez in the School of Public Health's Department of Epidemiology and Biostatistics is the first to establish a connection between phys...
https://medicalxpress.com/news/2024-03-abuse-cardiovascular-disease-women-hiv.html
New research presented early ahead of this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024, Barcelona, 27-30 April) from a team of researchers in the Nether...
https://medicalxpress.com/news/2024-03-hiv-cell-culture-crispr-cas.html
University of Pittsburgh School of Medicine scientists have identified drug candidates that show promise to reverse the ability of HIV to escape detection by the immune system.
https://medicalxpress.com/news/2024-03-drug-candidate-unmask-latent-hiv.html
For people with HIV (PWH) and a history of suboptimal adherence to antiretroviral therapy, long-acting injectable treatment with cabotegravir and rilpivirine (LAI) is superior to oral standard of...
https://medicalxpress.com/news/2024-03-art-superior-standard-poorly-adherent.html
Researchers at Weill Cornell Medicine have shown that three months of social worker follow-up support to people hospitalized with HIV in Tanzania had health benefits at low cost. The protocol sho...
https://medicalxpress.com/news/2024-03-hospitalized-patients-hiv-tanzania.html
Nurse-led management can lower cardiovascular risk factors among individuals with HIV receiving antiretroviral therapy, according to a study published online March 5 in JAMA Network Open.
https://medicalxpress.com/news/2024-03-nurse-strategy-cardiovascular-factors-people.html
A team of University of Michigan researchers has successfully modified a naturally occurring chemical compound in the lab, resulting in advanced lead compounds with anti-HIV activity.
https://medicalxpress.com/news/2024-03-anti-hiv-drug-compound-nature.html
Recent work from the laboratory of Elena Martinelli, Ph.D., MPH, professor of Medicine in the Division of Infectious Diseases and of Microbiology–Immunology, has discovered how inhibiting an im...
https://medicalxpress.com/news/2024-03-inhibitory-pathways-immune-response-hiv.html
Four children have remained free of detectable HIV for more than one year after their antiretroviral therapy (ART) was paused to see if they could achieve HIV remission, according to a presentati...
https://medicalxpress.com/news/2024-03-children-surpass-year-hiv-remission.html
Results of the third and final cohort of the DELIVER (MTN-042) Phase Ib study found no safety concerns with use of the monthly dapivirine vaginal ring beginning during the second trimester of pre...
https://medicalxpress.com/news/2024-03-safety-dapivirine-vaginal-trimesters.html
A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according to ...
https://medicalxpress.com/news/2024-03-semaglutide-severity-common-liver-disease.html
In the U.S., sexual and gender minority populations are disproportionately affected by HIV. Pre-exposure prophylaxis (PrEP) is a key prevention method, but its effectiveness relies on consistent ...
https://medicalxpress.com/news/2024-03-explores-prep-discontinuation-national-cohort.html
The elevated cardiovascular disease risk among people with HIV is even greater than predicted by a standard risk calculator in several groups, including Black people and cisgender women, accordin...
https://medicalxpress.com/news/2024-03-common-tools-underestimate-cardiovascular-event.html
New research definitively shows that HIV antiretrovirals can be taken together with gender-affirming hormone therapy without changing how well either drug works. The study findings can help healt...
https://medicalxpress.com/news/2024-03-hiv-medication-safely-gender-affirming.html
New research from the University of Washington shows that condom use has been trending downward among younger gay and bisexual men over the last decade, even when they aren't taking pre-exposure ...
https://medicalxpress.com/news/2024-02-qa-decline-condom-awareness.html
Molecular simulations on the JUWELS supercomputer show how the HIV-1 virus is able to evade the human immune system. The newly discovered mechanism could prove to be the Achilles' heel of the vir...
https://medicalxpress.com/news/2024-02-qa-supercomputer-simulations-hiv-therapies.html
In the quest to overcome quality-of-life altering side effects linked to combination antiretroviral therapy (cART) in people with HIV, a team of Johns Hopkins researchers has developed a new way ...
https://medicalxpress.com/news/2024-02-method-aims-optimize-hiv-treatments.html